Algo version: 0.98b
SynCore Biotechnology is listed at the TWO Exchange
SynCore Biotechnology [4192.TWO]
TWO Sector: Healthcare Industry:Biotechnology

Is SynCore Biotechnology stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for SynCore Biotechnology 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD111.46, you would have made a loss of TWD-75.76 per share or -67.97%

No, the average daily trading liquidity for SynCore Biotechnology is TWD6 050 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

SynCore Biotechnology has no real debt, which is good in periods of high inflation. The company has a very low net profit margin of 1.59%, which is challenging.

We have calculated the inflation risk for SynCore Biotechnology to be low [0.5 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.